If you are part of a multidisciplinary team treating patients with bleeding and clotting disorders, the Thrombosis and Hemostasis Summit of North America (THSNA) is a “must attend” event. This comprehensive scientific meeting includes three full days focused on the most current issues in hemostasis and thrombosis. THSNA is a special collaboration among nine hemostasis and thrombosis nonprofit organizations, including the National Hemophilia Foundation (NHF), that share a commitment to improving the quality of patient care. The summit will be held at the Hyatt Regency Chicago, May 3-5, 2012.
General sessions will explore topics with broad appeal that balance inpatient and outpatient issues, adult and pediatric medicine, issues in prevention, diagnosis and treatment including:
- The future of anticoagulation
- Treating the female patient
- Update of common bleeding and thrombotic disorders
- What’s new in the American College of Chest Physicians (ACCP) Guidelines
- Difficult cases
Educational tracks provide offer more in-depth topics in the areas you choose, such as:
- Hemophilia, platelet disorders, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, and inhibitors
- Venous thromboembolism treatment, new anticoagulants and interventional approaches
- Laboratory assays used for factor VIII monitoring, thrombophilia testing and heparin-induced thrombocytopenia
A clinical pre-conference, poster sessions, oral abstract presentations of original research and meet the experts programs provide even more options. Continuing education credits will be available for physicians, nurses, pharmacists and laboratory professionals.
Leadership Sponsors include the American Thrombosis and Hemostasis Network, the Anticoagulation Forum, the Hemostasis & Thrombosis Research Society and the North American Specialized Coagulation Laboratory Association.
Collaborating Sponsors include NHF, the Association of Hemophilia Clinic Directors of Canada, the Foundation for Women & Girls with Blood Disorders, the National Blood Clot Alliance and the Thrombosis Interest Group of Canada.
THSNA Supporters include the American Heart Association’s Council on PVD, the Centers for Disease Control and Prevention, ClotConnect, the International Society on Thrombosis and Haemostasis, the Platelet Disorder Support Association and the Venous Disease Coalition Steering Committee.
Register or learn more about the THSNA summit on the THSNA Web site.